.jpg)
IN VITRO METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF MALIGNANT MELANOMA
Patent number:
EP21382617.5
No items found.
A group of single nucleotide polymorphisms (SNPs) associated with the risk and aggressiveness of malignant melanoma has been identified. In this way, an in vitro method based on the identification of these biomarkers for the diagnosis and/or prognosis of malignant melanoma is proposed and, additionally, it allows determining if these patients respond adequately to treatment.
Countries:
Spain
Regions:
Andalusia
Centers:
UNIVERSIDAD DE GRANADA, SERVICIO ANDALUZ DE SALUD
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 2 – technology concept formulated
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
It enables early diagnosis of MM and its prognosis. Assessment of response to treatment. Improves precision medicine. The biological sample to be analyzed is easily accessible. No specific equipment is necessary. Simple method.
Comments